International Review of Ophthalmology

Previous Articles     Next Articles

Research on familial vitreous amyloidosis

YU Qiang1, HUANG Xing2, YANG Zhu-min2, WANG Xian2   

  1. 1. Guizhou Medical University,Guiyang 550004,China; 2. Department of Ophthalmology, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
  • Received:2018-07-14 Online:2018-12-22 Published:2018-12-22
  • Contact: WANG Xian,Email:liangliang830@126.com
  • Supported by:

    Science and Technology Project of Guizhou(2013-3069)

Abstract:

Familial vitreous amyloidosis(FVA) is a rare autosomal dominant genetic disease in which certain molecular gene mutations cause the corresponding proteins to denature, forming insoluble amyloids deposit in vitreous,resulting in a gradual decline in visual function. The transthyretin(TTR) mutation is the most common type of gene mutation. FVA is a rare disease of vitreous degeneration, whose diagnosis depends on the Congo red staining positive reaction of the intraoperative vitreous specimen. Vitrectomy is the most direct and effective treatment. (Int Rev Ophthalmol, 2018, 42:   401-405)